FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KDM4C-ARMC2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KDM4C-ARMC2
FusionPDB ID: 41826
FusionGDB2.0 ID: 41826
HgeneTgene
Gene symbol

KDM4C

ARMC2

Gene ID

23081

84071

Gene namelysine demethylase 4Carmadillo repeat containing 2
SynonymsGASC1|JHDM3C|JMJD2C|TDRD14CSPGF38|bA787I22.1
Cytomap

9p24.1

6q21

Type of geneprotein-codingprotein-coding
Descriptionlysine-specific demethylase 4CJmjC domain-containing histone demethylation protein 3Cgene amplified in squamous cell carcinoma 1 proteinjumonji domain-containing protein 2Clysine (K)-specific demethylase 4Ctudor domain containing 14Carmadillo repeat-containing protein 2
Modification date2020032920200313
UniProtAcc

Q9H3R0

Main function of 5'-partner protein: FUNCTION: Histone demethylase that specifically demethylates 'Lys-9' and 'Lys-36' residues of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylates trimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has no activity on mono- and dimethylated residues. Demethylation of Lys residue generates formaldehyde and succinate. {ECO:0000269|PubMed:16603238, ECO:0000269|PubMed:28262558}.

Q8NEN0

Main function of 5'-partner protein: FUNCTION: Required for sperm flagellum axoneme organization and function (By similarity). Involved in axonemal central pair complex assembly and/or stability (By similarity). {ECO:0000250|UniProtKB:Q3URY6}.
Ensembl transtripts involved in fusion geneENST idsENST00000489243, ENST00000381306, 
ENST00000381309, ENST00000442236, 
ENST00000535193, ENST00000536108, 
ENST00000543771, ENST00000401787, 
ENST00000428870, 
ENST00000368972, 
ENST00000392644, ENST00000481850, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score22 X 15 X 12=396015 X 15 X 7=1575
# samples 2216
** MAII scorelog2(22/3960*10)=-4.16992500144231
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(16/1575*10)=-3.29920801838728
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KDM4C [Title/Abstract] AND ARMC2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KDM4C [Title/Abstract] AND ARMC2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KDM4C(6893232)-ARMC2(109220897), # samples:3
Anticipated loss of major functional domain due to fusion event.KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
KDM4C-ARMC2 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneKDM4C

GO:0006357

regulation of transcription by RNA polymerase II

17277772

HgeneKDM4C

GO:0033169

histone H3-K9 demethylation

18066052|21914792

HgeneKDM4C

GO:0070544

histone H3-K36 demethylation

21914792



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:6893232/chr6:109220897)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KDM4C (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ARMC2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000535193KDM4Cchr96893232+ENST00000368972ARMC2chr6109232102+29221073832653856
ENST00000535193KDM4Cchr96893232+ENST00000392644ARMC2chr6109232102+31231073832653856
ENST00000543771KDM4Cchr96893232+ENST00000368972ARMC2chr6109232102+335015014483081877
ENST00000543771KDM4Cchr96893232+ENST00000392644ARMC2chr6109232102+355115014483081877
ENST00000381306KDM4Cchr96893232+ENST00000368972ARMC2chr6109232102+333514864333066877
ENST00000381306KDM4Cchr96893232+ENST00000392644ARMC2chr6109232102+353614864333066877
ENST00000381309KDM4Cchr96893232+ENST00000368972ARMC2chr6109232102+333514864333066877
ENST00000381309KDM4Cchr96893232+ENST00000392644ARMC2chr6109232102+353614864333066877
ENST00000442236KDM4Cchr96893232+ENST00000368972ARMC2chr6109232102+27478982502478742
ENST00000442236KDM4Cchr96893232+ENST00000392644ARMC2chr6109232102+29488982502478742
ENST00000536108KDM4Cchr96893232+ENST00000368972ARMC2chr6109232102+27589094622489675
ENST00000536108KDM4Cchr96893232+ENST00000392644ARMC2chr6109232102+29599094622489675

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000535193ENST00000368972KDM4Cchr96893232+ARMC2chr6109232102+0.0006612550.9993387
ENST00000535193ENST00000392644KDM4Cchr96893232+ARMC2chr6109232102+0.0005276870.9994723
ENST00000543771ENST00000368972KDM4Cchr96893232+ARMC2chr6109232102+0.0007659480.9992341
ENST00000543771ENST00000392644KDM4Cchr96893232+ARMC2chr6109232102+0.0005771360.9994229
ENST00000381306ENST00000368972KDM4Cchr96893232+ARMC2chr6109232102+0.0007680310.99923193
ENST00000381306ENST00000392644KDM4Cchr96893232+ARMC2chr6109232102+0.0005773830.99942267
ENST00000381309ENST00000368972KDM4Cchr96893232+ARMC2chr6109232102+0.0007680310.99923193
ENST00000381309ENST00000392644KDM4Cchr96893232+ARMC2chr6109232102+0.0005773830.99942267
ENST00000442236ENST00000368972KDM4Cchr96893232+ARMC2chr6109232102+0.0009030680.999097
ENST00000442236ENST00000392644KDM4Cchr96893232+ARMC2chr6109232102+0.0007074740.9992925
ENST00000536108ENST00000368972KDM4Cchr96893232+ARMC2chr6109232102+0.0009837520.9990163
ENST00000536108ENST00000392644KDM4Cchr96893232+ARMC2chr6109232102+0.0007698110.99923015

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KDM4C-ARMC2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KDM4Cchr96893232ARMC2chr61092321021073330TVRWIDYGKVAKLLKVSRKNLLNVCK
KDM4Cchr96893232ARMC2chr61092321021486351TVRWIDYGKVAKLLKVSRKNLLNVCK
KDM4Cchr96893232ARMC2chr61092321021501351TVRWIDYGKVAKLLKVSRKNLLNVCK
KDM4Cchr96893232ARMC2chr6109232102898216TVRWIDYGKVAKLLKVSRKNLLNVCK
KDM4Cchr96893232ARMC2chr6109232102909149TVRWIDYGKVAKLLKVSRKNLLNVCK

Top

Potential FusionNeoAntigen Information of KDM4C-ARMC2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM4C-ARMC2_6893232_109232102.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM4C-ARMC2chr96893232chr61092321021486HLA-B08:01LLKVSRKNL0.9940.56461221
KDM4C-ARMC2chr96893232chr61092321021486HLA-A31:02VAKLLKVSR0.80290.586918
KDM4C-ARMC2chr96893232chr61092321021486HLA-A74:09KVAKLLKVSR0.99270.6408818
KDM4C-ARMC2chr96893232chr61092321021486HLA-A74:03KVAKLLKVSR0.99270.6408818
KDM4C-ARMC2chr96893232chr61092321021486HLA-A74:11KVAKLLKVSR0.99270.6408818
KDM4C-ARMC2chr96893232chr61092321021486HLA-A31:02KVAKLLKVSR0.95690.6115818
KDM4C-ARMC2chr96893232chr61092321021486HLA-A31:01VAKLLKVSR0.90540.5391918
KDM4C-ARMC2chr96893232chr61092321021486HLA-A31:01KVAKLLKVSR0.99220.5912818
KDM4C-ARMC2chr96893232chr61092321021486HLA-C15:02KVAKLLKV0.99950.8038816
KDM4C-ARMC2chr96893232chr61092321021486HLA-B08:18LLKVSRKNL0.9940.56461221
KDM4C-ARMC2chr96893232chr61092321021486HLA-B08:12LLKVSRKNL0.61150.7481221
KDM4C-ARMC2chr96893232chr61092321021486HLA-A74:01KVAKLLKVSR0.99270.6408818

Top

Potential FusionNeoAntigen Information of KDM4C-ARMC2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KDM4C-ARMC2_6893232_109232102.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1113VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1117VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1117KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1117AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1152VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1152KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1152AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1189VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1189KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1331VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1354VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1376VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1377VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1401VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1401KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1401AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1404VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1404KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1405VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1405KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1405AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1407VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1407KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1407AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1408VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1408KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1408AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1411VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1411KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1414VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1416VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1418VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1418KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1418AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1423VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1423KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1423AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1426VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1426KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1426AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1428VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1428KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1428AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1431VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1431KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1432VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1432KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1434VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1435VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1435KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1435AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1436VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1438VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1438KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1438AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1439VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1439KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1442VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1443VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1443KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1443AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1444VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1445VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1445KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1445AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1450VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1450KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1450AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1454VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1454KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1454AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1455VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1455KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1456VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1456KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1456AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1458VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1458KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1458AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1459VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1459KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1459AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1460VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1460KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1460AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1461VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1461KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1462VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1462KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1462AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1464VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1464KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1465VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1468VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1468KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1470VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1470KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1470AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1471VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1471KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1471AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1472VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1472KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1475VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1475KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1475AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1481VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1482VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1482KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1482AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1486VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1486KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1486AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1487VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1487KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1487AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1488VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1488KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1488AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1490VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1490KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1490AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1491VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1491KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1491AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1493VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1493KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1495VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1495KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1496VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1496KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1496AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1497VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1497KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1497AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1499VAKLLKVSRKNLLNV924
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1499KVAKLLKVSRKNLLN823
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1499AKLLKVSRKNLLNVC1025
KDM4C-ARMC2chr96893232chr61092321021486DRB1-1499GKVAKLLKVSRKNLL722

Top

Fusion breakpoint peptide structures of KDM4C-ARMC2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10649YGKVAKLLKVSRKNKDM4CARMC2chr96893232chr61092321021486

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KDM4C-ARMC2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10649YGKVAKLLKVSRKN-7.15543-7.26883
HLA-B14:023BVN10649YGKVAKLLKVSRKN-4.77435-5.80965
HLA-B52:013W3910649YGKVAKLLKVSRKN-6.80875-6.92215
HLA-B52:013W3910649YGKVAKLLKVSRKN-4.20386-5.23916
HLA-A11:014UQ210649YGKVAKLLKVSRKN-7.5194-8.5547
HLA-A11:014UQ210649YGKVAKLLKVSRKN-6.9601-7.0735
HLA-A24:025HGA10649YGKVAKLLKVSRKN-7.52403-7.63743
HLA-A24:025HGA10649YGKVAKLLKVSRKN-5.82433-6.85963
HLA-B27:056PYJ10649YGKVAKLLKVSRKN-3.28285-4.31815
HLA-B44:053DX810649YGKVAKLLKVSRKN-5.91172-6.94702
HLA-B44:053DX810649YGKVAKLLKVSRKN-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of KDM4C-ARMC2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KDM4C-ARMC2chr96893232chr61092321021221LLKVSRKNLTTGCTTAAAGTGAGTAGAAAGAATCTT
KDM4C-ARMC2chr96893232chr6109232102816KVAKLLKVAAAGTTGCCAAATTGCTTAAAGTG
KDM4C-ARMC2chr96893232chr6109232102818KVAKLLKVSRAAAGTTGCCAAATTGCTTAAAGTGAGTAGA
KDM4C-ARMC2chr96893232chr6109232102918VAKLLKVSRGTTGCCAAATTGCTTAAAGTGAGTAGA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KDM4C-ARMC2chr96893232chr61092321021025AKLLKVSRKNLLNVCGCCAAATTGCTTAAAGTGAGTAGAAAGAATCTTCTTAATGTCTGC
KDM4C-ARMC2chr96893232chr6109232102722GKVAKLLKVSRKNLLGGAAAAGTTGCCAAATTGCTTAAAGTGAGTAGAAAGAATCTTCTT
KDM4C-ARMC2chr96893232chr6109232102823KVAKLLKVSRKNLLNAAAGTTGCCAAATTGCTTAAAGTGAGTAGAAAGAATCTTCTTAAT
KDM4C-ARMC2chr96893232chr6109232102924VAKLLKVSRKNLLNVGTTGCCAAATTGCTTAAAGTGAGTAGAAAGAATCTTCTTAATGTC

Top

Information of the samples that have these potential fusion neoantigens of KDM4C-ARMC2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAKDM4C-ARMC2chr96893232ENST00000381306chr6109232102ENST00000368972TCGA-EW-A6S9-01A

Top

Potential target of CAR-T therapy development for KDM4C-ARMC2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to KDM4C-ARMC2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KDM4C-ARMC2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource